Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and Eszopiclone for Obstructive Sleep Apnea After Palate Surgery
NCT05953610Phase 2Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide, eszopiclone in obstructive sleep apnea (OSA), sponsored by University of California, Los Angeles. Started Jan 2024; status: recruiting.
02
Drugs
acetazolamideeszopiclone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05953610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05953610.